I. Gilaberte

发表

Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With ST-Segment Elevation Myocardial Infarction and Left Ventricular Dysfunction: A Multicenter Randomized, Double-Blind, and Placebo-Controlled Clinical Trial

J. Bogaert, F. Fernández‐Avilés, P. Claus, 2018, Circulation research.

[Development and validation of the Social Functioning Scale, short version, in schizophrenia for its use in the clinical practice].

J. Alonso, I. Gilaberte, A. Ciudad, 2008, Actas espanolas de psiquiatria.

[Remission and relapse in the outpatient treatment of patients with schizophrenia. Outcomes at 3 years].

J. Haro, J. Alonso, M. Bousoño, 2008, Actas espanolas de psiquiatria.

Duloxetine in the treatment of major depressive disorder: an open-label study

M. Detke, J. Hudson, J. Watkin, 2007, BMC psychiatry.

Comparative efficacy and tolerability among different selective serotonin re-uptake inhibitors and venlafaxine in a naturalistic setting.

I. Gilaberte, F. Arias, J. Padín, 1998, International journal of psychiatry in clinical practice.

Fluoxetine in the Prevention of Depressive Recurrences: A Double-Blind Study

R. Martín-Santos, M. Bernardo, A. Montejo, 2001, Journal of clinical psychopharmacology.

Spanish Medical Students’ Attitudes and Views towards Mental Health and Psychiatry: a Multicentric Cross-Sectional Study

V. Pérez, A. Salazar, I. Failde, 2014, Academic Psychiatry.

Olanzapine Orally Disintegrating Tablet: A Review of Efficacy and Compliance

L. San, M. Casillas, I. Gilaberte, 2008, CNS neuroscience & therapeutics.

Recovery from schizophrenia: Results from a 1-year follow-up observational study of patients in symptomatic remission

L. San, J. Bobes, E. Alvarez, 2009, Schizophrenia Research.

Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: Prevalence and associations in a cross-sectional study

L. San, J. Bobes, I. Gilaberte, 2007, European Psychiatry.

Clinical meaningful outcomes in schizophrenia: remission and recovery.

L. San, J. Bobes, E. Alvarez, 2011, Revista de psiquiatria y salud mental.

Validation of the translation of an instrument to measure reliability of written information on treatment choices: a study on attention deficit/hyperactivity disorder (ADHD).

A. Montoya, I. Gilaberte, N. Llopis, 2011, Education for health.

Measuring Schizophrenia Remission in Clinical Practice

I. Gilaberte, A. Ciudad, A. Casado, 2008, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

SSRI antidepressant use patterns and their relation to clinical global impression scores: a naturalistic study.

W. Crown, A. Montejo, J. Sacristán, 1999 .

Worse Quality of Life for Children With Newly Diagnosed Attention-Deficit/Hyperactivity Disorder, Compared With Asthmatic and Healthy Children

A. Hervás, C. Soutullo, I. Gilaberte, 2005, Pediatrics.

Social and occupational functioning impairment in patients in partial versus complete remission of a major depressive disorder episode. A six-month prospective epidemiological study

I. Gilaberte, I. Romera, J. M. Menchón, 2010, European Psychiatry.

Optimal cutoff point of the Hamilton Rating Scale for Depression according to normal levels of social and occupational functioning

V. Pérez, J. Menchón, I. Gilaberte, 2011, Psychiatry Research.

Sembragiline in Moderate Alzheimer’s Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD)

J. Dukart, R. Doody, P. Fontoura, 2017, Journal of Alzheimer's disease : JAD.

Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn’s Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial

J. Panés, D. García-Olmo, A. Spinelli, 2021, Diseases of the colon and rectum.

Use of olanzapine in dysphoric mania.

M. Tohen, F. Mosquera, A. González-Pinto, 2001, Journal of affective disorders.

Functioning and symptomatic outcomes in patients with bipolar I disorder in syndromal remission: a 1-year, prospective, observational cohort study.

E. Vieta, A. Montoya, M. Casillas, 2010, Journal of affective disorders.

[Open study of fluoxetine in children with autism].

I. Gilaberte, M. Alcamí Pertejo, M. Peral Guerra, 2000, Actas espanolas de psiquiatria.

Broader conceptualization of remission assessed by the remission from depression questionnaire and its association with symptomatic remission: a prospective, multicenter, observational study

L. Agüera-Ortiz, M. Zimmerman, Á. Moríñigo, 2016, BMC Psychiatry.

Efficacy of lifestyle interventions in physical health management of patients with severe mental illness

F. Chacón, I. Gilaberte, F. Mora, 2011, Annals of general psychiatry.

Duloxetine in the prevention of relapse of major depressive disorder

M. Detke, S. Montgomery, A. Montejo, 2006, British Journal of Psychiatry.

Changes of Urine Dihydroxyphenylglycol to Norepinephrine Ratio in Children With Attention-Deficit Hyperactivity Disorder (ADHD) Treated With Atomoxetine

J. Alda, A. Montoya, I. Gilaberte, 2011, Journal of child neurology.

Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naïve children and adolescents with attention deficit/hyperactivity disorder

J. Alda, A. Hervás, A. Montoya, 2009, Current medical research and opinion.

Olanzapine as Long-Term Adjunctive Therapy in Treatment-Resistant Bipolar Disorder

M. Tohen, E. Vieta, C. Gastó, 2001, Journal of clinical psychopharmacology.

Augmentation of Fluoxetine's Antidepressant Action by Pindolol: Analysis of Clinical, Pharmacokinetic, and Methodologic Factors

D. Puigdemont, V. Pérez, E. Alvarez, 2001, Journal of clinical psychopharmacology.

Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment

V. Pérez, E. Alvarez, F. Artigas, 1997, The Lancet.

Originals Remission and relapse in the ambulatory treatment of patients with schizophrenia . Outcomes at 3 years

J. Haro, M. Bousoño, D. Suarez, 2008 .

The Schizophrenia Outpatient Health Outcomes (SOHO) study: 3-year results of antipsychotic treatment discontinuation and related clinical factors in Spain

J. Haro, M. Bousoño, D. Suarez, 2008, European Psychiatry.

Antidepressant Use and Clinical and Economic Outcomes in a Primary Care Psychiatry Center in Spain

W. Crown, A. Montejo, J. Sacristán, 1999 .

Individual residual symptoms and functional impairment in patients with depression

V. Pérez, I. Gilaberte, I. Romera, 2014, Psychiatry Research.

Residual symptoms and functioning in depression, does the type of residual symptom matter? A post-hoc analysis

V. Pérez, I. Gilaberte, I. Romera, 2013, BMC Psychiatry.

Early vs. conventional switching of antidepressants in patients with MDD and moderate to severe pain: a double-blind randomized study.

V. Pérez, J. Menchón, A. Schacht, 2012, Journal of affective disorders.

Early response and remission as predictors of a good outcome of a major depressive episode at 12-month follow-up: a prospective, longitudinal, observational study.

M. Roca, A. Valladares, M. Casillas, 2012, The Journal of clinical psychiatry.

Remission in schizophrenia: Results from a 1-year follow-up observational study

L. San, J. Bobes, E. Alvarez, 2009, Schizophrenia Research.

[Pattern of usage of new antidepressants in clinical practice].

A. Montejo, J. Sacristán, I. Gilaberte, 1998, Actas luso-espanolas de neurologia, psiquiatria y ciencias afines.

Early Switch Strategy in Patients With Major Depressive Disorder: A Double-Blind, Randomized Study

P. Svanborg, V. Pérez, J. Menchón, 2012, Journal of clinical psychopharmacology.

Different levels of lack of improvement at 4 weeks of escitalopram treatment as predictors of poor 8-week outcome in MDD.

J. Menchón, A. Schacht, V. Pérez-Solà, 2013, Journal of Affective Disorders.

Relapse and therapeutic interventions in a 1-year observational cohort study of nonadherent outpatients with schizophrenia

L. San, M. Bernardo, J. Olivares, 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Treatment patterns and health care resource utilization in a 1-year observational cohort study of outpatients with schizophrenia at risk of nonadherence treated with long-acting injectable antipsychotics

L. San, M. Bernardo, T. Dilla, 2011, Patient preference and adherence.

Relationship of somatic symptoms with depression severity, quality of life, and health resources utilization in patients with major depressive disorder seeking primary health care in Spain.

J. García-Campayo, J. Ayuso-Mateos, F. Rodríguez‐Artalejo, 2008, Primary care companion to the Journal of clinical psychiatry.

P.1.078 Pindolol augments the antidepressant efficacy of fluoxetine. Results of a double-blind, controlled trial

V. Pérez, F. Artigas, D. Faries, 1996, European Neuropsychopharmacology.

Generalized anxiety disorder, with or without co-morbid major depressive disorder, in primary care: prevalence of painful somatic symptoms, functioning and health status.

A. Montejo, D. Desaiah, I. Gilaberte, 2010, Journal of affective disorders.

Treatment benefits of duloxetine in major depressive disorder as assessed by number needed to treat

D. Kajdasz, D. Desaiah, I. Gilaberte, 2006, International clinical psychopharmacology.

Remission and functioning in major depressive disorder.

V. Pérez, I. Gilaberte, I. Romera, 2013, Actas espanolas de psiquiatria.

Systematic depression screening in high-risk patients attending primary care: a pragmatic cluster-randomized trial

A. Montejo, J. A. Lozano, E. Aragonès, 2013, BMC Psychiatry.

Functional impairment related to painful physical symptoms in patients with generalized anxiety disorder with or without comorbid major depressive disorder: post hoc analysis of a cross-sectional study

A. Montejo, D. Desaiah, I. Gilaberte, 2011, BMC psychiatry.

Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naïve children and adolescents with attention deficit/hyperactivity disorder

J. Alda, A. Hervás, A. Montoya, 2009, Current medical research and opinion.

Changes of Urine Dihydroxyphenylglycol to Norepinephrine Ratio in Children With Attention-Deficit Hyperactivity Disorder (ADHD) Treated With Atomoxetine

J. Alda, A. Montoya, I. Gilaberte, 2011, Journal of child neurology.